Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early dexamethasone in hospitalized patients with COVID-19 pneumonia at high risk of ARDS
2021-001028-16Phase 4Terminated
- Sponsor
- Fundación para la Investigación e Innovación Biomédica del Hospital Universitario Infanta Sofía y del Hospital Universitario del Henares
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronavirus pneumonia comparing Early dexamethasone with Control / standard of care (2 arms). Started Sep 2021; status: terminated.
02
Drugs
dexamethasone
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on 2021-001028-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001028-16.